Neurocrine Biosciences (Nasdaq: NBIX) has announced positive results from its Phase IV KINECT-PRO study, showing that ...

We’re trying to treat unstable and traumatised patients in a public mental health care system that has become unstable itself ...

By Melissa Karen Sances For the Valley Advocate Her phone pinged and a grey bubble rose to the surface: “Are you ready to ...